ES2172376B1 - Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. - Google Patents

Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Info

Publication number
ES2172376B1
ES2172376B1 ES200000185A ES200000185A ES2172376B1 ES 2172376 B1 ES2172376 B1 ES 2172376B1 ES 200000185 A ES200000185 A ES 200000185A ES 200000185 A ES200000185 A ES 200000185A ES 2172376 B1 ES2172376 B1 ES 2172376B1
Authority
ES
Spain
Prior art keywords
sub
pharmaceutical compositions
compositions containing
preparation procedure
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES200000185A
Other languages
English (en)
Other versions
ES2172376A1 (es
Inventor
Martinez Diego Ma Cortes
Escrig Nuria Cabedo
Ros Inmaculada Andreu
Del Castillo Almudena Bermejo
Ghanem Atassi
Alain Pierre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Priority to ES200000185A priority Critical patent/ES2172376B1/es
Priority to PCT/FR2001/000245 priority patent/WO2001055117A1/fr
Priority to AU35606/01A priority patent/AU3560601A/en
Publication of ES2172376A1 publication Critical patent/ES2172376A1/es
Application granted granted Critical
Publication of ES2172376B1 publication Critical patent/ES2172376B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nuevos derivados de isoquinoleinas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen. Compuesto de fórmula (I): **FIGURA01** en la cual: - R{sub,1} representa un grupo alcoxi, alqueniloxi o arilalquiloxi, - R{sub,2}, R{sub,3} y R{sub,4}, idénticos o diferentes, representan cada uno un átomo de hidrógeno o de halógeno o un grupo hidroxi, alcoxi, alquilo, arilalquiloxi, nitro o amino eventualmente sustituido, = representa un enlace sencillo o doble. - n representa 0 ó 1 - X representa un átomo de carbono o un grupo S(O)-, - Y representa un enlace, un grupo alquileno, alquenileno o -NH-, sus isómeros así como sus sales de adición de un ácido farmacéuticamente aceptable. Medicamentos.
ES200000185A 2000-01-28 2000-01-28 Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. Expired - Lifetime ES2172376B1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES200000185A ES2172376B1 (es) 2000-01-28 2000-01-28 Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
PCT/FR2001/000245 WO2001055117A1 (fr) 2000-01-28 2001-01-26 Nouveaux derives d'isoquinoleines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU35606/01A AU3560601A (en) 2000-01-28 2001-01-26 Novel isoquinoline derivatives, preparation method and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200000185A ES2172376B1 (es) 2000-01-28 2000-01-28 Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Publications (2)

Publication Number Publication Date
ES2172376A1 ES2172376A1 (es) 2002-09-16
ES2172376B1 true ES2172376B1 (es) 2003-11-16

Family

ID=8492086

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200000185A Expired - Lifetime ES2172376B1 (es) 2000-01-28 2000-01-28 Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Country Status (3)

Country Link
AU (1) AU3560601A (es)
ES (1) ES2172376B1 (es)
WO (1) WO2001055117A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ535366A (en) 2002-03-13 2007-07-27 Univ Tennessee Res Foundation Substituted tetrahydroisoquinoline compounds, methods of making, and their use
FR2853649B1 (fr) * 2003-04-09 2006-07-14 Servier Lab Nouveaux derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7067529B2 (en) * 2003-05-19 2006-06-27 Hoffmann-La Roche Inc. Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
EP1675845A2 (en) * 2003-10-16 2006-07-05 F. Hoffmann-La Roche Ag Glutamine fructose-6-phosphate amidotransferase (gfat) inhibitors
RU2009112685A (ru) 2006-09-20 2010-10-27 Маллинкродт Инк. (Us) Получение замещенных морфинан-6-онов и их солей и промежуточных соединений
WO2008073390A2 (en) * 2006-12-11 2008-06-19 Mallinckrodt Inc. Preparation of 3,4-dihydroisoquinolines from an acid and an amine
US9040726B2 (en) 2007-03-06 2015-05-26 Mallinckrodt Llc Process for the preparation of quaternary N-alkyl morphinan alkaloid salts
NZ580536A (en) 2007-03-06 2010-11-26 Mallinckrodt Inc Process for the preparation of quaternary N-alkyl morphinan alkaloid salts
EP2285780B1 (en) 2008-05-27 2015-08-26 Mallinckrodt LLC Processes and compounds for the preparation of normorphinans
EP2331508B1 (en) 2008-09-03 2014-11-12 Mallinckrodt LLC Substituted berbines and processes for their synthesis
WO2021192726A1 (ja) * 2020-03-24 2021-09-30 学校法人東京医科大学 コリン取り込み抑制剤、細胞死誘導剤、抗がん剤、およびその用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9721964D0 (en) * 1997-10-16 1997-12-17 Pfizer Ltd Isoquinolines

Also Published As

Publication number Publication date
AU3560601A (en) 2001-08-07
ES2172376A1 (es) 2002-09-16
WO2001055117A1 (fr) 2001-08-02

Similar Documents

Publication Publication Date Title
ES2190396T3 (es) Nuevos compuestos amino-triazoles, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR034897A1 (es) Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos
MX9305379A (es) Nuevos derivados de aminoacidos, procedimiento para su preparacion y preparado farmaceutico que los contiene.
DK0889877T3 (da) Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer
CO4970713A1 (es) Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
HUP0400233A2 (hu) 1-típusú plazminogén aktivátor inhibitor (PAI-1) gátló szubsztituált naftil-indolszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
CO4650038A1 (es) Derivados del indazol sustituidos y compuestos relacionados
ECSP066541A (es) Nuevos derivados de piridazin-3(2h)-ona
ATE397605T1 (de) Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol
ES2187814T3 (es) Derivados de pirazolopiridinopiridazinonas y procedimiento para su preparacion.
ES2112650T3 (es) Sales de un derivado de indol antimigraña.
MX9300786A (es) Compuestos hipolipidaemicos.
ES2172376B1 (es) Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ECSP045278A (es) Compuestos de oxo-azabicíclicos
AR009938A1 (es) Nuevos derivados de arilglicinamida, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos
AR019190A1 (es) Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos
AR006606A1 (es) Derivados de isatina como inhibidores de la acetilcolinesterasa y analgesicos, composicion farmaceutica, metodos de tratamaiento, usos yprocedimiento de dichos derivados.
AR027335A1 (es) Compuestos de piperidina-4-sulfonamida, proceso de preparacion de los mismos, y composiciones farmaceuticas que los contienen
AR044943A1 (es) Procedimiento para la sintesis de perindopril y sales farmaceuticamente aceptables del mismo
NO20040382L (no) Kinolinderivater og anvendelse derav som antitumormidler
AR054584A1 (es) Inhibidores de la bomba de protones isotopicamente sustituidos
AR027454A1 (es) Derivados de beta-alanina, utiles como antagonistas de receptores, las composiciones farmaceuticas que las contienen y el uso de los mismos para lapreparacion de medicamentos
AR033779A1 (es) Compuestos utiles en la enfermedad de reflujo
UY27001A1 (es) Derivados de la indolilpiperidina como agentes antihistamínicos y antialérgicos
SE0301371D0 (sv) New Compounds

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20020916

Kind code of ref document: A1

Effective date: 20020916

FG2A Definitive protection

Ref document number: 2172376B1

Country of ref document: ES

FA2A Application withdrawn

Effective date: 20050301